Transcription Factor RTEF-1 Mediates α 1 -Adrenergic Reactivation of the Fetal Gene Program in Cardiac Myocytes

Abstract

Abstract —α 1 -Adrenergic receptor stimulation induces cardiac myocytes to hypertrophy and reactivates many fetal genes, including β-myosin heavy chain (βMyHC) and skeletal α-actin (SKA), by signaling through myocyte-specific CAT (M-CAT) cis elements, binding sites of the transcriptional enhancer factor-1 (TEF-1) family of transcription factors. To examine functional differences between TEF-1 and related to TEF-1 (RTEF-1) in α 1 -adrenergic reactivation of the fetal program, expression constructs were cotransfected with βMyHC and SKA promoter/reporter constructs in neonatal rat cardiac myocytes. TEF-1 overexpression tended to transactivate a minimal βMyHC promoter but significantly interfered with a minimal SKA promoter. In contrast, RTEF-1 transactivated both the minimal βMyHC and SKA promoters. TEF-1 and RTEF-1 also affected the α 1 -adrenergic response of the βMyHC and SKA promoters differently. TEF-1 had no effect. In contrast, RTEF-1 potentiated the α 1 -adrenergic responses of the SKA promoter and of a −3.3-kb βMyHC promoter. To determine why the promoters responded differently to TEF-1 and RTEF-1, promoters with mutated M-CAT elements were tested in the same way. The βMyHC promoter required an intact M-CAT element to respond to TEF-1 and RTEF-1, whereas the SKA promoter M-CAT was required for the TEF-1 response but not for the RTEF-1 response, suggesting that SKA promoter–specific cofactors may be involved. By competition gel shift assay, the M-CAT of the minimal βMyHC promoter had a lower affinity than that of the SKA promoter, which partly explains the different responses of these promoters to TEF-1. These results highlight functional differences between TEF-1 and RTEF-1 and suggest a novel function of RTEF-1 in mediating the α 1 -adrenergic response in hypertrophic cardiac myocytes.